Connection

Co-Authors

This is a "connection" page, showing publications co-authored by EHAB Y HANNA and MICHAEL ELLIOT KUPFERMAN.
Connection Strength

8.164
  1. Robotic surgery of the skull base. Otolaryngol Clin North Am. 2014 Jun; 47(3):415-23.
    View in: PubMed
    Score: 0.499
  2. Feasibility of a robotic surgical approach to reconstruct the skull base. Skull Base. 2011 Mar; 21(2):79-82.
    View in: PubMed
    Score: 0.402
  3. Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results. Arch Otolaryngol Head Neck Surg. 2009 Dec; 135(12):1219-24.
    View in: PubMed
    Score: 0.369
  4. Transantral robotic access to the pituitary gland. Otolaryngol Head Neck Surg. 2009 Sep; 141(3):413-5.
    View in: PubMed
    Score: 0.363
  5. Paragangliomas of the head and neck. Curr Oncol Rep. 2008 Mar; 10(2):156-61.
    View in: PubMed
    Score: 0.327
  6. Robotic endoscopic surgery of the skull base: a novel surgical approach. Arch Otolaryngol Head Neck Surg. 2007 Dec; 133(12):1209-14.
    View in: PubMed
    Score: 0.321
  7. Long-Term Outcomes of Olfactory Neuroblastoma: MD Anderson Cancer Center Experience and Review of the Literature. Laryngoscope. 2022 02; 132(2):290-297.
    View in: PubMed
    Score: 0.207
  8. Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses. Cancer. 2021 06 01; 127(11):1788-1795.
    View in: PubMed
    Score: 0.200
  9. Endoscopic resection of sinonasal malignancies. Head Neck. 2020 04; 42(4):645-652.
    View in: PubMed
    Score: 0.185
  10. Comparative transcriptome analysis of sinonasal inverted papilloma and associated squamous cell carcinoma: Out-HOXing developmental genes. Head Neck. 2019 09; 41(9):3090-3104.
    View in: PubMed
    Score: 0.177
  11. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. J Clin Oncol. 2019 02 20; 37(6):504-512.
    View in: PubMed
    Score: 0.173
  12. Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma. Ann Surg Oncol. 2018 Jun; 25(6):1723-1729.
    View in: PubMed
    Score: 0.165
  13. Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma. Cancer. 2018 02 01; 124(3):514-520.
    View in: PubMed
    Score: 0.159
  14. Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma. J Neurol Surg B Skull Base. 2017 Dec; 78(6):512-518.
    View in: PubMed
    Score: 0.157
  15. Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck. 2017 08; 39(8):1671-1679.
    View in: PubMed
    Score: 0.155
  16. Mutation status among patients with sinonasal mucosal melanoma and its impact on survival. Br J Cancer. 2017 Jun 06; 116(12):1564-1571.
    View in: PubMed
    Score: 0.155
  17. Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1926-34.
    View in: PubMed
    Score: 0.141
  18. Prognostic factors in adenocarcinoma of the salivary glands. Oral Oncol. 2015 Jun; 51(6):610-5.
    View in: PubMed
    Score: 0.134
  19. Impact of Chemoradiotherapy on CSF Leak Repair after Skull Base Surgery. J Neurol Surg B Skull Base. 2014 Oct; 75(5):354-7.
    View in: PubMed
    Score: 0.126
  20. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015 Mar; 9(1):51-9.
    View in: PubMed
    Score: 0.125
  21. Endoscopic resection of sinonasal cancers. Curr Oncol Rep. 2014 Feb; 16(2):369.
    View in: PubMed
    Score: 0.123
  22. Sinonasal adenocarcinoma: a 16-year experience at a single institution. Head Neck. 2014 Oct; 36(10):1490-6.
    View in: PubMed
    Score: 0.123
  23. Optimization of long-term outcomes for patients with esthesioneuroblastoma. Head Neck. 2014 Apr; 36(4):524-30.
    View in: PubMed
    Score: 0.118
  24. Primary sarcomas of the salivary glands: case series and literature review. Head Neck. 2013 Nov; 35(11):1551-7.
    View in: PubMed
    Score: 0.118
  25. Molecular profiling of sinonasal undifferentiated carcinoma. Head Neck. 2014 Jan; 36(1):15-21.
    View in: PubMed
    Score: 0.117
  26. Genetic testing in head and neck paraganglioma: who, what, and why? J Neurol Surg B Skull Base. 2013 Aug; 74(4):236-40.
    View in: PubMed
    Score: 0.116
  27. Esthesioneuroblastoma. Neurosurg Clin N Am. 2013 Jan; 24(1):51-65.
    View in: PubMed
    Score: 0.114
  28. Establishment and characterization of novel cell lines from sinonasal undifferentiated carcinoma. Clin Cancer Res. 2012 Nov 15; 18(22):6178-87.
    View in: PubMed
    Score: 0.112
  29. Minor salivary gland malignancies in the pediatric population. Head Neck. 2012 Nov; 34(11):1648-51.
    View in: PubMed
    Score: 0.107
  30. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer. 2012 Aug 15; 118(16):3928-36.
    View in: PubMed
    Score: 0.106
  31. Multimodality treatment for sinonasal neuroendocrine carcinoma. Head Neck. 2012 Oct; 34(10):1372-6.
    View in: PubMed
    Score: 0.105
  32. Surgical management of sinonasal hemangiopericytomas: a case series. Head Neck. 2012 Oct; 34(10):1492-6.
    View in: PubMed
    Score: 0.105
  33. Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glands. Cancer. 2012 Jun 01; 118(11):2872-8.
    View in: PubMed
    Score: 0.105
  34. Sinonasal malignancies in children: a 10-year, single-institutional review. Laryngoscope. 2011 Sep; 121(9):2001-3.
    View in: PubMed
    Score: 0.103
  35. Sinonasal and nasopharyngeal applications of the hand-held CO2 laser fiber. Int Forum Allergy Rhinol. 2011 Mar-Apr; 1(2):109-12.
    View in: PubMed
    Score: 0.101
  36. Primacy of surgery in the management of mucoepidermoid carcinoma in children. Head Neck. 2011 Dec; 33(12):1769-73.
    View in: PubMed
    Score: 0.100
  37. Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses. Arch Otolaryngol Head Neck Surg. 2011 Jan; 137(1):78-81.
    View in: PubMed
    Score: 0.099
  38. Modern multimodality therapy for pediatric nonorbital parameningeal sarcomas. Head Neck. 2010 Nov; 32(11):1501-5.
    View in: PubMed
    Score: 0.098
  39. Malignant head and neck paragangliomas: is there an optimal treatment strategy? Head Neck Oncol. 2010 Sep 23; 2:23.
    View in: PubMed
    Score: 0.098
  40. Theraputic targeting of Trk supresses tumor proliferation and enhances cisplatin activity in HNSCC. Cancer Biol Ther. 2010 Sep 15; 10(6):644-53.
    View in: PubMed
    Score: 0.097
  41. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center. Cancer. 2010 May 01; 116(9):2215-23.
    View in: PubMed
    Score: 0.095
  42. Paraganglioma of the endolarynx: a rare tumor in an uncommon location. Head Neck Oncol. 2010 Jan 19; 2:2.
    View in: PubMed
    Score: 0.093
  43. An orthotopic murine model of sinonasal malignancy. Clin Cancer Res. 2008 Nov 15; 14(22):7348-57.
    View in: PubMed
    Score: 0.086
  44. Sinonasal adenoid cystic carcinoma: the M. D. Anderson Cancer Center experience. Cancer. 2007 Dec 15; 110(12):2726-31.
    View in: PubMed
    Score: 0.081
  45. Long-term oncological outcomes for endoscopic endonasal versus open surgical approaches for anatomically matched, locally advanced stage T4 sinonasal malignancies with skull base involvement. J Neurosurg. 2024 Mar 01; 140(3):688-695.
    View in: PubMed
    Score: 0.060
  46. Predictors of postoperative performance status after surgical management of infratemporal fossa malignancies. Neurosurg Rev. 2023 Jun 29; 46(1):157.
    View in: PubMed
    Score: 0.059
  47. Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma. J Clin Oncol. 2023 05 20; 41(15):2843-2851.
    View in: PubMed
    Score: 0.058
  48. Soft Tissue Sarcomas of the Head and Neck Region with Skull Base/Intracranial Invasion: Review of Surgical Outcomes and Multimodal Treatment Strategies: A Retrospective Case Series. Curr Oncol. 2022 09 14; 29(9):6540-6550.
    View in: PubMed
    Score: 0.056
  49. The impact of expanded endoscopic approaches on oncologic and functional outcomes for clival malignancies:a case series. J Neurooncol. 2022 Sep; 159(3):627-635.
    View in: PubMed
    Score: 0.056
  50. Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors. Curr Oncol Rep. 2022 06; 24(6):775-781.
    View in: PubMed
    Score: 0.054
  51. Impact of salvage surgery for recurrent sinonasal cancers with skull base and intracranial involvement. J Neurosurg. 2022 Feb 04; 1-8.
    View in: PubMed
    Score: 0.054
  52. The neurosurgical management of sinonasal malignancies involving the anterior skull base: a 28-year experience at The MD Anderson Cancer Center. J Neurosurg. 2022 Jun 01; 136(6):1583-1591.
    View in: PubMed
    Score: 0.052
  53. Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies. Laryngoscope. 2021 05; 131(5):E1468-E1475.
    View in: PubMed
    Score: 0.049
  54. Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes. J Neurosurg. 2020 Jun 12; 134(5):1392-1398.
    View in: PubMed
    Score: 0.048
  55. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck. 2020 06; 42(6):1194-1201.
    View in: PubMed
    Score: 0.048
  56. Long-term quality of life after definitive treatment of sinonasal and nasopharyngeal malignancies. Laryngoscope. 2020 01; 130(1):86-93.
    View in: PubMed
    Score: 0.044
  57. Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavity. Head Neck. 2018 12; 40(12):2596-2605.
    View in: PubMed
    Score: 0.043
  58. Endoscopic endonasal transpterygoid transnasopharyngeal management of petroclival chondrosarcomas without medial extension. J Neurosurg. 2018 Aug 03; 131(1):184-191.
    View in: PubMed
    Score: 0.042
  59. Site-Specific Considerations in the Surgical Management of Skull Base Chondrosarcomas. Oper Neurosurg (Hagerstown). 2018 06 01; 14(6):611-619.
    View in: PubMed
    Score: 0.042
  60. Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma. Acta Neurochir (Wien). 2018 04; 160(4):731-740.
    View in: PubMed
    Score: 0.040
  61. Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb. Laryngoscope. 2018 06; 128(6):1274-1280.
    View in: PubMed
    Score: 0.040
  62. Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: A cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module. Head Neck. 2017 10; 39(10):2048-2056.
    View in: PubMed
    Score: 0.039
  63. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol. 2016 Jul-Aug; 6(4):241-247.
    View in: PubMed
    Score: 0.035
  64. Adenoid cystic carcinoma of the skull base: results with an aggressive multidisciplinary approach. J Neurosurg. 2016 Jan; 124(1):115-21.
    View in: PubMed
    Score: 0.034
  65. Orbital carcinomas treated with adjuvant intensity-modulated radiation therapy. Head Neck. 2016 04; 38 Suppl 1:E580-7.
    View in: PubMed
    Score: 0.034
  66. Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management. J Neurosurg. 2015 Sep; 123(3):781-8.
    View in: PubMed
    Score: 0.034
  67. Risk Factors and Prognosis for Myoepithelial Carcinoma of the Major Salivary Glands. Ann Surg Oncol. 2015 Oct; 22(11):3701-7.
    View in: PubMed
    Score: 0.033
  68. Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome. Head Neck Oncol. 2011 Jul 27; 3:32.
    View in: PubMed
    Score: 0.026
  69. Quality and performance indicators in an academic department of head and neck surgery. Arch Otolaryngol Head Neck Surg. 2010 Dec; 136(12):1212-8.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.